Q2 2026 Earnings Call February 1, 2026 7:30 PM ESTCompany ParticipantsMark Flynn - Investor RelationsThomas Spurling - ...

Typically, when our vision needs correction we visit a doctor. But Evan Mehlenbacher prayed for healing instead.

AI is reshaping clinical practice in retinal imaging and workflow optimization, according to Priv.-Doz. Dr. med. Jan H.

The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.

This week, Google introduced a new capability for its Gemini 3 Flash model called “Agentic Vision” that fundamentally changes ...

A new TG4 documentary follows the McNally family as they confront dad Seán’s diagnosis of a rare form of Alzheimer’s ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

The ADAPT trial involves 70 refractory glaucoma patients, focusing on a 12-month primary effectiveness endpoint to evaluate the Calibreye TGT Surgical System. The Calibreye system is the first ...

Patients with infantile nystagmus had significant gains in near and distance visual acuity as well as stereopsis following regular sessions of vision training with RevitalVision software, according to ...

South Carolinians who wear glasses or contact lenses will have to continue getting fitted for a new prescription at a ...

In this Healio Video Perspective from Hawaiian Eye 2026, Jay S. Pepose, MD, PhD, of Pepose Vision Institute, discusses the impact of vitreous opacities. Pepose urged anterior segment surgeons not to ...

Electronic retinal implants such as the PRIMA system bypass damaged cells to restore partial central vision, bringing ...